Keywords: amgen, submits, sbla, aranesp, biotechnology, giant, submitted

Amgen submits sBLA for Aranesp

Article | 16 May 2005

Print This

US biotechnology giant Amgen has submitted a supplemental Biologics License Application to the US Food and Drug Administration for extended ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in